ロード中...
New treatments/targets for primary biliary cholangitis
Primary biliary cholangitis (PBC) is an autoimmune, cholestatic, chronic liver disease that ultimately progresses towards cirrhosis and liver failure if untreated. While ursodeoxycholic acid has been established as standard of care for PBC in the last few decades, significant advances in second-line...
保存先:
| 出版年: | JHEP Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7001536/ https://ncbi.nlm.nih.gov/pubmed/32039371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2019.05.005 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|